Kay M. Uppington

Cell death in prion disease

K. M. Uppington, Kay M. Uppington, 2008 .

Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury

A. Medford, L. Armstrong, A. Millar, 2009, Respiratory research.

Modelling neurodegeneration in prion disease – applications for drug development

David R. Brown, K. M. Uppington, Kay M. Uppington, 2007, Expert opinion on drug discovery.

Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.

A. Medford, L. Armstrong, A. Millar, 2004, American journal of respiratory cell and molecular biology.

Differential expression of Toll‐like receptor (TLR)‐2 and TLR‐4 on monocytes in human sepsis

A. Medford, L. Armstrong, A. Millar, 2004, Clinical and experimental immunology.

Contribution of TNF-α Converting Enzyme and Proteinase-3 to TNF-α Processing in Human Alveolar Macrophages

L. Armstrong, A. Millar, S. I. Godinho, 2006 .

Interleukin-22: a potential immunomodulatory molecule in the lung.

L. Armstrong, A. Millar, H. Whittington, 2004, American journal of respiratory cell and molecular biology.

Resistance of cell lines to prion toxicity aided by phospho‐ERK expression

David R. Brown, K. M. Uppington, Kay M. Uppington, 2008, Journal of neurochemistry.